SEC Form 4 · accession 0001505148-17-000015
PSYCHEMEDICS CORP · PMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
A Clinton Allen
Director
Period of report
May 4, 2017
Accepted (ET)
May 5, 2017 · 4:45 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000806517
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $18.87 | May 4, 2017 | A | 14,000 | A | — | May 4, 2027 | Common Stock, $.005 Par Value | 14,000 | 14,000 | D |
Explanation of responses
- F1The option becomes exercisable with respect to 50% of the shares on April 30, 2018 and with respect to the remaining 50% on April 30, 2019, so long as the recipient continues as a director of the Issuer through each such respective vesting date.